• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Nanotherapeutics for the treatment of inflammatory bowel disease.

作者信息

Chen Qiubing, Xiao Bo, Merlin Didier

机构信息

a Institute for Clean Energy and Advanced Materials, Faculty of Materials and Energy , Southwest University , Chongqing , P. R. China.

b Institute for Biomedical Sciences, Center for Diagnostics and Therapeutics , Georgia State University , Atlanta , GA , USA.

出版信息

Expert Rev Gastroenterol Hepatol. 2017 Jun;11(6):495-497. doi: 10.1080/17474124.2017.1309282. Epub 2017 Mar 24.

DOI:10.1080/17474124.2017.1309282
PMID:28317404
Abstract
摘要

相似文献

1
Nanotherapeutics for the treatment of inflammatory bowel disease.用于治疗炎症性肠病的纳米疗法。
Expert Rev Gastroenterol Hepatol. 2017 Jun;11(6):495-497. doi: 10.1080/17474124.2017.1309282. Epub 2017 Mar 24.
2
Nanomedicine and drug delivery strategies for treatment of inflammatory bowel disease.用于治疗炎症性肠病的纳米医学与药物递送策略
World J Gastroenterol. 2015 Oct 28;21(40):11343-52. doi: 10.3748/wjg.v21.i40.11343.
3
Site-specific targeted drug delivery systems for the treatment of inflammatory bowel disease.用于治疗炎症性肠病的靶向药物传递系统。
Biomed Pharmacother. 2020 Sep;129:110486. doi: 10.1016/j.biopha.2020.110486. Epub 2020 Jul 8.
4
Methotrexate for inflammatory bowel disease: time for reconsideration.甲氨蝶呤用于炎症性肠病：是时候重新考虑了。
Expert Rev Gastroenterol Hepatol. 2019 May;13(5):407-409. doi: 10.1080/17474124.2019.1596797. Epub 2019 Mar 21.
5
Review article: The pharmacokinetics and pharmacodynamics of drugs used in inflammatory bowel disease treatment.综述文章：用于治疗炎症性肠病的药物的药代动力学和药效学
Eur J Clin Pharmacol. 2015 Jul;71(7):773-99. doi: 10.1007/s00228-015-1862-7. Epub 2015 May 27.
6
How Failure Can Fuel Improvements in Early Drug Development for Inflammatory Bowel Diseases.失败如何推动炎症性肠病早期药物研发的改进
Gastroenterology. 2016 May;150(5):1061-1066. doi: 10.1053/j.gastro.2016.03.011. Epub 2016 Mar 24.
7
Biologics for inflammatory bowel diseases in the Asia-Pacific: can we afford to use them, can we afford not to?亚太地区炎症性肠病的生物制剂：我们用得起吗，不用得起吗？
J Gastroenterol Hepatol. 2009 Jul;24(7):1160-2. doi: 10.1111/j.1440-1746.2009.05896.x.
8
Identification of Patients With Variants in TPMT and Dose Reduction Reduces Hematologic Events During Thiopurine Treatment of Inflammatory Bowel Disease.鉴定 TPMT 变异患者并减少巯嘌呤剂量可降低炎症性肠病患者在硫唑嘌呤治疗期间的血液学事件。
Gastroenterology. 2015 Oct;149(4):907-17.e7. doi: 10.1053/j.gastro.2015.06.002. Epub 2015 Jun 11.
9
The problem of adherence to therapy in ulcerative colitis and the potential utility of multi-matrix system (MMX) technology.溃疡性结肠炎的治疗依从性问题以及多基质系统（MMX）技术的潜在效用。
Expert Rev Gastroenterol Hepatol. 2017 Jan;11(1):33-41. doi: 10.1080/17474124.2017.1256200. Epub 2016 Nov 14.
10
Biosimilar infliximab (CT-P13) in the treatment of inflammatory bowel disease: A Norwegian observational study.生物类似药英夫利昔单抗（CT-P13）治疗炎症性肠病：一项挪威观察性研究。
Expert Rev Gastroenterol Hepatol. 2015;9 Suppl 1:45-52. doi: 10.1586/17474124.2015.1091308.

引用本文的文献

1
pH and redox dual response nano-suppository for the treatment of ulcerative colitis.pH 和氧化还原双重响应纳米栓剂治疗溃疡性结肠炎。
Drug Deliv Transl Res. 2024 Jul;14(7):1954-1968. doi: 10.1007/s13346-023-01499-1. Epub 2024 Jan 8.
2
Reactive Oxygen Species-Responsive Polymeric Prodrug Nanoparticles for Selective and Effective Treatment of Inflammatory Diseases.用于炎症性疾病的选择性和有效治疗的活性氧响应性聚合物前药纳米粒子。
Adv Healthc Mater. 2023 Nov;12(29):e2301394. doi: 10.1002/adhm.202301394. Epub 2023 Aug 17.
3
Atomic Force Microscopy to Characterize Ginger Lipid-Derived Nanoparticles (GLDNP).
原子力显微镜表征生姜脂质衍生纳米颗粒（GLDNP）。
Bio Protoc. 2021 Apr 5;11(7):e3969. doi: 10.21769/BioProtoc.3969.
4
Lactoferrin-mediated macrophage targeting delivery and patchouli alcohol-based therapeutic strategy for inflammatory bowel diseases.乳铁蛋白介导的巨噬细胞靶向递送及基于广藿香醇的炎症性肠病治疗策略
Acta Pharm Sin B. 2020 Oct;10(10):1966-1976. doi: 10.1016/j.apsb.2020.07.019. Epub 2020 Aug 5.
5
Can naturally occurring nanoparticle-based targeted drug delivery effectively treat inflammatory bowel disease?基于天然纳米颗粒的靶向药物递送能否有效治疗炎症性肠病？
Expert Opin Drug Deliv. 2020 Jan;17(1):1-4. doi: 10.1080/17425247.2020.1698543. Epub 2019 Nov 28.
6
Isolation, Purification, and Characterization of Ginger-derived Nanoparticles (GDNPs) from Ginger, Rhizome of .从姜科植物姜的根茎中分离、纯化及表征姜衍生纳米颗粒（GDNPs）
Bio Protoc. 2019 Oct 5;9(19). doi: 10.21769/BioProtoc.3390.
7
Advances in Pharmaceutical Strategies Enhancing the Efficiencies of Oral Colon-Targeted Delivery Systems in Inflammatory Bowel Disease.医药策略的进展提高了炎症性肠病口服结肠靶向递药系统的效率。
Molecules. 2018 Jul 4;23(7):1622. doi: 10.3390/molecules23071622.